Trial Profile
Effect of PSMA Targeting Small Molecule Therapeutic (1095) for the treatment of metastatic prostate cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2015
Price :
$35
*
At a glance
- Drugs LNTH 1095 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 02 Mar 2015 New trial record